Published in Medical Device Business Week, January 24th, 2007
Siemens will collaborate with Alzheimer researchers at the University of California, Los Angeles (UCLA) to launch a phase 1, open label, single center safety study of one of the first imaging biomarkers designed to identify Alzheimer disease pathology specifically. The study will employ a new diagnostic technique developed by UCLA researchers that combines the new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.